<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00443664</url>
  </required_header>
  <id_info>
    <org_study_id>DSRB-A/06/165</org_study_id>
    <nct_id>NCT00443664</nct_id>
  </id_info>
  <brief_title>External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma</brief_title>
  <acronym>EMDLT</acronym>
  <official_title>External Micropulse Diode Laser Transscleral Trabeculoplasty(EMDLT) For Severe Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To prove that external contact micropulse diode laser trabeculoplasty (EMDLT) can
      significantly lower intraocular pressure in cases of advanced open angle glaucoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Micropulse diode laser trabeculoplasty applied through a gonioscopy len has been shown to be
      effective in lower the pressure for patients with primary open angle glaucoma (POAG). We
      believe that applied externally, the contact diode micropulse laser will be effective in
      lowering intraocular pressure for patients with advance open angle glaucoma with minimal side
      effects
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The amount of pressure lowering after EXTERNAL MICROPULSE DIODE LASER TRANSSCLERAL TRABECULOPLASTY (EMDLT) treatment.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study of safety of EXTERNAL MICROPULSE DIODE LASER TRANSSCLERAL TRABECULOPLASTY (EMDLT) treatment</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EXTERNAL MICROPULSE DIODE LASER TRANSSCLERAL TRABECULOPLASTY</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Diagnosis of Primary Open Angle Glaucoma

               -  Advanced glaucoma with intraocular pressure higher than 21mmHg on one or more
                  topical medications (for at least 2 months)

               -  Visual acuity worse than 6/6

               -  Age more than 21 years

               -  Poor candidate for additional filtration surgery

        Exclusion Criteria:

          -  • Age less than 21 years

               -  Any eye surgery within 2 months of enrolment

               -  Any patient with rubeosis

               -  Unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul TK Chew, MBBS,MMedOph</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul TK Chew, MBBS,MMedoph</last_name>
    <phone>+65-6772-5317</phone>
    <email>ophchewp@nus.edu.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul TK Chew, MBBS,MMedoph</last_name>
      <phone>+65-6772-5317</phone>
      <email>ophchewp@nus.edu.sg</email>
    </contact>
    <investigator>
      <last_name>Paul TK Chew, MBBS,MMedoph</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jin F Cheng, MBCHB, MMED</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace Dizon, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group. Ophthalmology. 1990 Nov;97(11):1403-13.</citation>
    <PMID>2255512</PMID>
  </reference>
  <reference>
    <citation>Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001 Apr;108(4):773-9.</citation>
    <PMID>11297496</PMID>
  </reference>
  <reference>
    <citation>Ho CL Micropulse Diode Trans-scleral Cyclophotocoagulation Asian Journal of ophth. 2001 supplement. vol 3,no 3,4</citation>
  </reference>
  <reference>
    <citation>Ingvoldstad DD, Krishna R, Willoughby L. MicroPulse Diode Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in the treatment of Open angle glaucoma. Presented at ARVO 2005, Poster 123.</citation>
  </reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2007</study_first_submitted>
  <study_first_submitted_qc>March 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2007</study_first_posted>
  <last_update_submitted>May 13, 2008</last_update_submitted>
  <last_update_submitted_qc>May 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2008</last_update_posted>
  <responsible_party>
    <name_title>Paul TK Chew, MBBS,MMedoph</name_title>
    <organization>National University Hospital, Singapore</organization>
  </responsible_party>
  <keyword>Primary Open Angle Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

